Practical Comparison of the BioFire FilmArray Pneumonia Panel to Routine Diagnostic Methods and Potential Impact on Antimicrobial Stewardship in Adult Hospitalized Patients with Lower Respiratory Tract Infections
Top Cited Papers
Open Access
- 24 June 2020
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 58 (7)
- https://doi.org/10.1128/jcm.00135-20
Abstract
Lower respiratory tract infections, including hospital-acquired and ventilator-associated pneumonia, are common in hospitalized patient populations. Standard methods frequently fail to identify the infectious etiology due to the polymicrobial nature of respiratory specimens and the necessity of ordering specific tests to identify viral agents. The potential severity of these infections combined with a failure to clearly identify the causative pathogen results in administration of empirical antibiotic agents based on clinical presentation and other risk factors. We examined the impact of the multiplexed, semiquantitative BioFire FilmArray Pneumonia panel (PN panel) test on laboratory reporting for 259 adult inpatients submitting bronchoalveolar lavage (BAL) specimens for laboratory analysis. The PN panel demonstrated a combined 96.2% positive percent agreement (PPA) and 98.1% negative percent agreement (NPA) for the qualitative identification of 15 bacterial targets compared to routine bacterial culture. Semiquantitative values reported by the PN panel were frequently higher than values reported by culture, resulting in semiquantitative agreement (within the same log10 value) of 43.6% between the PN panel and culture; however, all bacterial targets reported as >105 CFU/ml in culture were reported as ≥105 genomic copies/ml by the PN panel. Viral targets were identified by the PN panel in 17.7% of specimens tested, of which 39.1% were detected in conjunction with a bacterial target. A review of patient medical records, including clinically prescribed antibiotics, revealed the potential for antibiotic adjustment in 70.7% of patients based on the PN panel result, including discontinuation or de-escalation in 48.2% of patients, resulting in an average savings of 6.2 antibiotic days/patient.Keywords
This publication has 40 references indexed in Scilit:
- Hospital-acquired pneumonia and ventilator-associated pneumoniaCurrent Opinion in Pulmonary Medicine, 2013
- Routine use of Staphylococcus aureus rapid diagnostic test in patients with suspected ventilator-associated pneumoniaCritical Care, 2013
- Early versus late oseltamivir treatment in severely ill patients with 2009 pandemic influenza A (H1N1): speed is lifeJournal of Antimicrobial Chemotherapy, 2011
- An Antimicrobial Stewardship Program’s Impact with Rapid Polymerase Chain Reaction Methicillin‐ResistantStaphylococcus aureus/S. aureusBlood Culture Test in Patients withS. aureusBacteremiaClinical Infectious Diseases, 2010
- Human Metapneumovirus Infections in AdultsArchives of Internal Medicine, 2008
- Factors impacting on length of stay and mortality of community-acquired pneumoniaClinical Microbiology & Infection, 2008
- Quantitative detection of Streptococcus pneumoniae from sputum samples with real-time quantitative polymerase chain reaction for etiologic diagnosis of community-acquired pneumoniaDiagnostic Microbiology and Infectious Disease, 2008
- Etiologic Diagnosis of Adult Bacterial Pneumonia by Culture and PCR Applied to Respiratory Tract SamplesJournal of Clinical Microbiology, 2006
- Appropriateness and delay to initiate therapy in ventilator-associated pneumoniaEuropean Respiratory Journal, 2006
- Ventilator-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2002